Strasbourg Cedex 2

• An Open-label Study of XEN1101 in Epilepsy Recruiting
  2022-502282-24-00 5 2024-02-14 Primary generalized tonic-clonic seizures
• A Phase 2 Study of Teclistamab in Combination with Daratumumab or Lenalidomide in Elderly Patients with Newly Diagnosed Multiple Myeloma - I … Recruiting
  2024-514101-65-00 4 2023-12-21 Multiple Myeloma
• Study comparing thymoglobulin to grafalon, two treatments used to prevent graft versus host disease in elderly patients with acute myeloid l … Recruiting
  2023-504555-27-00 5 2023-11-28 Myelodysplastic syndrome (MDS)
• For patients with active multiple sclerosis, impact of annual versus semi-annual infusions of ocrelizumab after 2 years of initial treatment … Recruiting
  2023-505420-62-00 5 2023-11-09 Multiple sclerosis
• CITAR - Comparison of the efficacy and safety of early use of IL-6R blockade with tocilizumab in combination with short-term glucocorticoids … Recruiting
  2022-501130-33-00 4 2023-10-11 Patients with histologically (or via cytology) confirmed cancer that d
• A Modular, Multi-part, Multi-arm, Open-label, Phase I/II Study to Evaluate the Safety and Tolerability of GRWD5769 Alone and in Combination … Recruiting
  2023-504845-30-00 7 2023-10-05 Solid malignancies
• Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) Recruiting
  2022-502281-25-00 5 2023-09-27 Focal Onset Seizures
• Benefit of transplantation after Complete Response In Patients with T-cell lymphoma Recruiting
  2022-501710-62-02 6 2023-06-07 Peripheral T-cell lymphoma (PTCL)
• A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Efficacy of VX- 880 in Subjects Who Have Type 1 Diabetes Mellitus With Impaire … Recruiting
  2024-513929-23-00 10 2023-05-26 Type 1 Diabetes Mellitus with Impaired Hypoglycemic Awareness and Seve
• RIISC Recruiting
  2024-513669-38-00 5 2023-05-17 Stroke, Ischemic, TIA, Cardiac Disease, Atherosclerosis, Myocardial In
• EDEN : Etude de désescalade thérapeutique et d'évaluation du marqueur miRNA M371 pour les séminomes de stade IIa/IIb < 3 cm Recruiting
  2024-514636-25-00 4 2023-05-04 Stage IIa/IIb < 3 cm seminoma
• « Effect of sedative and anxiolytic sedation on children experience after general anesthesia » PEDIA_prem study. Recruiting
  2022-501124-23-00 5 2023-04-18 General anesthesia and sedative and anxiolytic sedation
• PREPARE - Intrapapillary botulinum toxin injection for PREvention of post-surgical PAncREatic fistula Recruiting
  2024-514929-33-00 5 2023-03-27 PANCREATIC FISTULA
• Randomized prospective trial evaluating the efficacy of the antiCD38 monoclonal antibody isatuximab in the treatment of PCRA by major ABO mi … Recruiting
  2024-514351-14-00 4 2023-02-20 Pure cell red aplasia by major ABO mismatch after allogeneic hematopoi
• A study to learn more about how safe the study treatment finerenone is in long-term use when taken with an ACE inhibitor or angiotensin rece … Recruiting
  2023-504885-50-00 5 2022-11-07 Treatment of children with chronic kidney disease and proteinuria
• Efficacy and Safety Study of Nipocalimab for Adults with CIDP Recruiting
  2023-508425-28-00 4 2022-10-24 Chronic Inflammatory Demyelinating Polyneuropathy
• A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC and Lenalidomide (Tec-DR) and Talquetamab in Combination … Recruiting
  2023-503442-30-00 5 2022-10-14 Multiple Myeloma
• ASPIC - Antimicrobial Stewardship for Ventilator Associated Pneumonia in Intensive Care Recruiting
  2024-513327-16-00 5 2022-09-20 Intensive care
• MetroWilms Recruiting
  2022-502687-20-00 4 2022-09-14 Wilms tumor
• Asciminib Roll-over Study Recruiting
  2023-507557-16-00 5 2022-08-31 chronic myelogenous leukemia (CML) or Philadelphia Chromosome positive
• Baricitinib in patients with relapsing or naïve dermatomyositis (BIRD) Recruiting
  2024-511899-32-00 10 2022-08-31 Dermatomyositis; Baricitinib in patients with relapsing or naïve derma
• Randomised phase III trial of ADT +/- darolutamide in frail men with castration-naïve de novo metastatic prostate cancer Recruiting
  2022-502425-18-00 5 2022-04-19 Adenocarcinoma of the prostate
• DZR123 (CPI-0209) in Patients with Advanced Solid Tumors and Lymphomas Recruiting
  2023-508002-20-00 7 2021-10-21 advanced, solid, relapsed tumors / advanced tumors: human lymphomas /
• Oxytocin versus Prostaglandins for labor Induction of women with an unfavorable Cervix after 24 hours of cervical ripening: a multicenter no … Recruiting
  2024-517675-20-00 11 2021-09-28 Labor Induction of women with an unfavorable Cervix after 24 hours of

Showing 169–192 of 355 trials